Cellbricks Therapeutics
PrivateLast Round
Seed
Mar 25, 2026
Total Funding Raised
$10.07M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cellbricks Therapeutics operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Seed round in March 2026.
Cellbricks Therapeutics is a biotechnology company that develops biofabricated human tissue implants for regenerative medicine, reconstructive surgery, and wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellbricks Therapeutics Comparables
Compare Cellbricks Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FluidForm Bio | 78% | |
| Aspect Biosystems | 77% | |
| Trestle Biotherapeutics | 76% |
For institutional investors. Book with your work email.
Cellbricks Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 25, 2026 | ||||
| Seed | Sep 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellbricks Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Riceberg Ventures | Seed |
| Federal Ministry of Research, Technology, and Space | Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| Silicon Roundabout Ventures | Seed |
| b.value AG | Seed |
| ACT Venture Partners | Seed |
| SPRIND | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 35, 121% of headcount.
- Mar 25, 2026
$10M raised in Seed round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 10, 2026
Cellbricks GmbH takes IFA Pitch Battle 2026 on Sep 6th '26 in Germany, winning the pitch competition on the Dream Stage.
For institutional investors. Book with your work email.
Cellbricks Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellbricks Therapeutics's valuation, stock price, and market status.
Is Cellbricks Therapeutics a public or private company?
Cellbricks Therapeutics is a private company.
What is the current stock price of Cellbricks Therapeutics?
Cellbricks Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cellbricks Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellbricks Therapeutics worth (valuation)?
Valuation information for Cellbricks Therapeutics is not publicly available.
Can I buy Cellbricks Therapeutics stock?
Cellbricks Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellbricks Therapeutics's last funding round?
Cellbricks Therapeutics's most recent funding round was Seed on March 25, 2026.
Who are the main investors in Cellbricks Therapeutics?
Key investors in Cellbricks Therapeutics include Silicon Roundabout Ventures.
Will Cellbricks Therapeutics IPO soon?
No public IPO plans have been announced for Cellbricks Therapeutics.
How can I track Cellbricks Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cellbricks Therapeutics's shares on secondary markets.